TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Panafarma Medical Consult AB
Closing information (x1000 EUR)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
21
|
25
|
36 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
0
|
4
|
3 |
| EBITDA |
0
|
4
|
3 |
| Total assets |
33
|
31
|
43 |
| Current assets |
33
|
31
|
43 |
| Current liabilities |
11
|
10
|
19 |
| Equity capital |
20
|
20
|
23 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
60.6%
|
64.5%
|
53.5% |
| Turnover per employee |
10
|
12
|
18 |
| Profit as a percentage of turnover |
0%
|
16.0%
|
8.3% |
| Return on assets (ROA) |
0%
|
12.9%
|
7.0% |
| Current ratio |
300%
|
310.0%
|
226.3% |
| Return on equity (ROE) |
0%
|
20.0%
|
13.0% |
| Change turnover |
-5
|
-7
|
4 |
| Change turnover % |
-20%
|
-22%
|
11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.